Cancer Care

Modern science has affirmed the therapeutic importance of mistletoe, through identification of the viscotoxins (literally, "mistletoe toxins"), lectins, and alkaloids thought to be responsible for its anticancer and immune modifying activities. Presently 60% of all cancer patients in Germany and Switzerland are prescribed mistletoe at some point in their treatment.

Although mistletoe therapy is generally used as a complementary therapy to conventional chemotherapy and radiation, many patients who have either failed chemotherapy or chosen against it, have used mistletoe successfully. More research is needed to study the effectiveness of mistletoe as a stand alone therapy for cancer. Our clinical experience supports its use in all types of cancer, whether the patient is using conventional therapies or not.

You can access links to research about mistletoe HERE.

You can find information about a US study being conducted at John’s Hopkins HERE.